Intraoperative identification of sentinel lymph node in patients with malignant melanoma
1997

Identifying Sentinel Lymph Nodes in Melanoma Patients

Sample size: 35 publication Evidence: moderate

Author Information

Author(s): MK Lingam, RM Mackie, AJ McKay

Primary Institution: Gartnavel General Hospital, West Glasgow Hospitals University NHS Trust and University Department of Dermatology, Glasgow University

Hypothesis

Embolic metastases occur along lymphatic channels to a 'sentinel' lymph node nearest the site of the primary malignant melanoma.

Conclusion

The technique of intraoperative lymphatic mapping is promising and can identify sentinel nodes in melanoma patients, revealing micrometastases in some cases.

Supporting Evidence

  • All 35 patients had clinically assessed stage I disease.
  • Nine out of 35 patients (26%) had evidence of micrometastatic disease.
  • Sentinel nodes were identified in all patients using the blue dye technique.

Takeaway

Doctors can use a special blue dye to find the first lymph node that might have cancer when someone has melanoma, helping them decide if more treatment is needed.

Methodology

The study involved injecting patent blue V dye into the skin around the melanoma and then surgically identifying the sentinel lymph node.

Limitations

The study may not account for all cases of nodal basin skipping, where metastases could be present in nodes not identified as sentinel nodes.

Participant Demographics

The study included 35 patients, 25 women and 10 men, with a mean age of 57 years, all with clinically assessed stage I melanoma.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication